Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

91.18 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Jun 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move' ↗

July 24, 2024

Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc.

Via Benzinga

Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024

July 17, 2024

From Edwards Lifesciences Corporation

Via Business Wire

Edwards Lifesciences to Acquire Innovalve

July 15, 2024

From Edwards Lifesciences Corporation

Via Business Wire

P/E Ratio Insights for Edwards Lifesciences ↗

July 11, 2024

Via Benzinga

$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today ↗

July 05, 2024

Via Benzinga

The Analyst Landscape: 13 Takes On Edwards Lifesciences ↗

July 02, 2024

Via Benzinga

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗

July 21, 2024

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Via Benzinga

Peering Into Edwards Lifesciences's Recent Short Interest ↗

June 21, 2024

Via Benzinga

$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today ↗

June 20, 2024

Via Benzinga

UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades' ↗

July 11, 2024

UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591.

Via Benzinga

Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review ↗

June 07, 2024

The Nasdaq and S&P 500 hit record highs, but small caps retreated.

Via Investor's Business Daily

Topics Stocks

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR

June 05, 2024

From Edwards Lifesciences Corporation

Via Business Wire

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today ↗

May 30, 2024

Via Benzinga

What Analysts Are Saying About Edwards Lifesciences Stock ↗

May 30, 2024

Via Benzinga

Looking Into Edwards Lifesciences's Recent Short Interest ↗

May 29, 2024

Via Benzinga

BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details ↗

June 03, 2024

BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring...

Via Benzinga

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal ↗

June 03, 2024

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.

Via Investor's Business Daily

Edwards Lifesciences to Sell Critical Care to BD

June 03, 2024

From Edwards Lifesciences Corporation

Via Business Wire

Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today ↗

May 15, 2024

Via Benzinga

Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint ↗

May 14, 2024

Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent actions aim to ensure fair competition, affordability, as Meril alleges...

Via Benzinga

Topics Intellectual Property

Assessing Edwards Lifesciences: Insights From 11 Financial Analysts ↗

May 07, 2024

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today ↗

April 26, 2024

Via Benzinga

Decoding Edwards Lifesciences's Options Activity: What's the Big Picture? ↗

April 25, 2024

Via Benzinga

Is It Time To Get Defensive With Healthcare Stocks? ↗

May 13, 2024

Based in Irvine, California, Edwards Lifesciences is a prominent American medical technology firm.

Via Talk Markets

Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy' ↗

May 01, 2024

Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta," he added.

Via Benzinga

Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗

April 26, 2024

Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.

Via Investor's Business Daily

Behind the Scenes of Edwards Lifesciences's Latest Options Trends ↗

April 18, 2024

Via Benzinga

EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024 ↗

April 25, 2024

EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff ↗

April 25, 2024

The company also raised its outlook for the year and now expects 8% to 10% sales growth.

Via Investor's Business Daily

Edwards Lifesciences Reports First Quarter Results

April 25, 2024

From Edwards Lifesciences Corporation

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Edwards Lifesciences (NY:EW)

All News about Edwards Lifesciences

Starting at $3.75/week.

Subscribe Today